Company brief: QuiX Quantum
Information only, not investment advice. This view does not rate, score or recommend any company or investor. Figures are as published by the sources named, with their dates; missing evidence is shown as not covered, never as a low value.
Brief dated 2026-11-03. Figures assembled on 2026-11-02 from the stored copies of the sources named in each section.
Use the print command of your browser to keep this brief as a PDF. Links stay readable in print.
Company and sources
- Country
- Netherlands
- SME in CORDIS
- Yes
- Technology areas of its EU projects
- Quantum computing and simulation, Quantum sensing and metrology, Enabling technologies and supply chain
Legal entities linked to this company after a review of name and country:
EU grants
Takes part in 10 EU-funded quantum projects. EU contribution received: EUR 6,007,023.75 (net EU contribution CORDIS records for the company in these projects; not the project budgets and not payments).
EIC schemes named by the CORDIS funding scheme
- EIC Accelerator (grant only): 1 project
- EIC Pathfinder: 1 project
Source: CORDIS, Publications Office of the European Union, retrieved 2026-10-16.
Patent families
4 distinct quantum patent families, looked up on 2026-10-27.
Source: European Patent Office, Open Patent Services, by applicant name in the quantum CPC groups; derived counts only. A count is not a measure of patent quality or ownership.
Publications
Status: not matched in OpenAlex yet.
Source: OpenAlex, CC0; the institution is matched by name and country.
Infrastructure
Status: the deployment tracker names this company in no contract award.
Announced funding rounds
| Date | Type and status | Amount | Investors (organisations) | Sources |
|---|---|---|---|---|
| 2025-07-10 | Series A Closed | EUR 15,000,000 As announced: secured €15 million in Series A funding | Invest-NL (including its Deep Tech Fund) (lead), European Innovation Council (EIC) and EIC Fund (lead), PhotonVentures, Oost NL, FORWARD.one | QuiX Quantum (Company press release, read 2026-10-23; Opening paragraph, 10 July 2025) |
| Currency | Total as announced | Rounds |
|---|---|---|
| EUR | EUR 15,000,000 | 1 |
Not added: 0 undisclosed, 0 not closed (targets, commitments and selections), 0 acquisitions or listings and 0 included in a later figure. Currencies are never converted or added together.
From grant to equity
- First EU-funded quantum project
- PHOQUSING, Collaborative research, innovation or coordination action (Horizon 2020), started 2020-09-01; EUR 3,305,955 (EU contribution (maximum grant agreed), the whole project). Source: CORDIS.
- First EIC Pathfinder or Transition project
- QuGANTIC, EIC Pathfinder (Horizon Europe), started 2023-02-01; EUR 3,194,262.50 (EU contribution (maximum grant agreed), the whole project). Source: CORDIS.
- First EIC Accelerator project
- QUQUP, EIC Accelerator (grant only) (Horizon Europe), started 2024-11-01; EUR 2,470,125 (EU contribution (maximum grant agreed), the whole project). Source: CORDIS.
- First round with the EIC Fund among the investors
- 2025-07-10, Series A, EUR 15,000,000 (as announced: secured €15 million in Series A funding). Sources: QuiX Quantum (read 2026-10-23; Opening paragraph, 10 July 2025)
- First equity round recorded in the portal
- 2025-07-10, Series A, EUR 15,000,000 (as announced: secured €15 million in Series A funding). Sources: QuiX Quantum (read 2026-10-23; Opening paragraph, 10 July 2025)
- Time between
- 58 months (4.8 years) from the start of the first project to the first equity round recorded in the portal.
Not covered
- Publications have not been matched in OpenAlex for this company yet.
- Valuations, revenues, ownership stakes, cap tables and individual investors are not collected.
- National grants, regional aid, loans and payments are not covered; EU figures are amounts awarded, not paid.
- Use of infrastructure as a customer is not recorded; only a named supplier role in the deployment tracker is shown.
- Nothing here is a rating, a recommendation or investment advice; figures are as published by their sources.